What type of study is this?

This is a Cohort Study study (also classified as: Validation Study).

December 8, 2025BloodOpen Access

Machine learning using bayesian networks to predict response in patients with newly diagnosed Acute Myeloid Leukemia

View Full Paper

Ask AI

Bookmark

Authors

Predictive model shows 74% accuracy in forecasting treatment response in newly diagnosed AML, supporting Bayesian networks for personalized therapy.

The predictive model achieved a 74% area under the ROC curve in assessing treatment response.
Key features influencing complete response included age, cytogenetic risk, and mutations in critical genes.
Analysis utilized a randomized dataset of 651 AML patients receiving various frontline therapies.
The model enhances personalized treatment strategies, highlighting pathways affecting response to therapy.

Chan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

December 8, 2025BloodOpen Access

View Full Paper

Ask AI

Bookmark

Authors

Predictive model shows 74% accuracy in forecasting treatment response in newly diagnosed AML, supporting Bayesian networks for personalized therapy.

The predictive model achieved a 74% area under the ROC curve in assessing treatment response.
Key features influencing complete response included age, cytogenetic risk, and mutations in critical genes.
Analysis utilized a randomized dataset of 651 AML patients receiving various frontline therapies.
The model enhances personalized treatment strategies, highlighting pathways affecting response to therapy.

Chan et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark